Journals / Çocuk Acil ve Yoğun Bakım Dergisi / 2020 / Cilt: 7 - Sayı: 3

An Unvaccinated Tetanus Case Discharged without Sequelae

Sekelsiz Taburcu Edilen Aşılanmamış Tetanoz Olgusu

Pages
136–139
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report, we aimed to present the follow-up and treatment of a patient with severe tetanus in pediatric intensive care unit.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Tetanus is an acute-onset disease that results from exposure to the exotoxins produced by Clostridium tetani.
📊
Key Findings & Data:The patient presented herein was 15 years old and unvaccinated, and had generalized tetanus and respiratory failure.
💡
Conclusion & Impact:In this report, we aimed to present the follow-up and treatment of a patient with severe tetanus in pediatric intensive care unit.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Tetanus is an acute-onset disease that results from exposure to the exotoxins produced by Clostridium tetani. It is characterized by tonic muscle spasms and has high morbidity and mortality. Respiratory failure is the most severe problem related to generalized tetanus. Mechanical ventilation is almost always mandatory for the therapy of respiratory insufficiency in patients with tetanus-developed airway obstruction. The patient presented herein was 15 years old and unvaccinated, and had generalized tetanus and respiratory failure. He was transported to pediatric intensive care unit following intubation. In this report, we aimed to present the follow-up and treatment of a patient with severe tetanus in pediatric intensive care unit.

Özet

Tetanoz, akut başlangıçlı, Clostridium tetani’nin ekzotoksiniyle meydana gelen bir hastalıktır. Tonik kas kasılmalarıyla karakterize olup, yüksek morbidite ve mortaliteye sahiptir. Solunum tutulumu jeneralize tetanozda görülen en ciddi sorundur. Hastalarda görülen solunum yetersizliği ve hava yolu tıkanıklığı sıklıkla ventilatör desteğini gerektirmektedir. Olgumuz 15 yaşında aşısız, jeneralize tip tetanoz tanısıyla solunum yetmezliği gelişen bir olguydu. Entübe edilerek yoğun bakım ünitesine alındı. Bu yazıda, hastanın çocuk yoğun bakımdaki takip ve tedavi süreci sunuldu.

🔖

Cite This Article

EMEKSİZ, S., PERK, O., PARLAKAY, A. Ö. (2020). An Unvaccinated Tetanus Case Discharged without Sequelae. Çocuk Acil ve Yoğun Bakım Dergisi, Cilt: 7 - Sayı: 3, 136–139. https://ajindex.com/articles/205853

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Wen SC, Webb C, Miles F, Wilson EJ. Tetanus in New Zealand children: Intensive care management of a vaccine preventable disease. Paediatr Child Health. 2016;52:1070-4
  2. Salman C, Sekban N, Döşemeci L, Cengiz M, Yılmaz M, et al. Tetanus in our intensive care unit: Evaluation of treatment, complications and mortality in 17 patients. Turk J Anaesthesiol Reanim. 2007;35:200-8
  3. Demir NA, Sumer S, Ural O, Ozturk S, Celik BJ. An alternative treatment approach in tetanus: Botulinum toxin. Tropical Doctor. 2015;45:46-8
  4. Edlich RF, Hill LG, Mahler CA, Cox MJ, Becker DG, et al. Management and prevention of tetanus. J Long Term Eff Med Implants. 2003;13:139-54
  5. The Pink Book: Course Textbook. Epidemiology and Prevention of Vaccine-Preventable Diseases. Chapter 21,Tetanus. 13th edition Atlanta Georgia: Centers for Disease Control and Prevention;2015:342-52. Available from: https: //www.cdc.gov/ vaccines/pubs/pinkbook/tetanus.html 6. Ergonul O, Egeli D, Kahyaoglu B, Bahar M, Etienne M, et al. An unexpected tetanus case. Lancet Infect Dis. 2016;16:746-52
  6. Koruk St, Söğüt Ö, Karaağaç L, Çalışır C, Yalçın Ş. Unforgettable disease: A very rapid tetanus case. JAEM. 2013;12:174-7
  7. Hassel B. Tetanus: pathophysiology, treatment, and the possibility of using botulinum toxin against tetanus-ınduced rigidity and spasms. Toxins (Basel). 2013;5:73-83
  8. Cook TM, Protheroe RT, Handel JM. Tetanus: a review of the literature. Br J Anaesth. 2001;87:477-87
  9. Gregorakos L, Kerezoudi E, Dimopoulos G, Thomaides T. Management of blood pressure instability in severe tetanus: the use of clonidine. Intensive Care Med. 1997;23:893-95
  10. Attygalle D, Rodrigo N. Magnesium as first line therapy in the management of tetanus: A prospevtive study of 40 patients. Anaesthesia. 2002;57:811-7
  11. Freshwater-Turner D, Udy A, Limpsn J, Deans R, Stuart J, et al. Autonomic dysfunction in tetanus- what lessons can be learnt with specific reference to alpha-2 agonists? Anaesthesia. 2007;62:1066- 70
  12. Sun C, Zhao H, Wang Z, Xue W, Lu S, et al. Prognostic factors for generalized tetanus in adults: A retrospective study in a Chinese hospital. Am J Emerg Med. 2019;37:254-9
  13. Girgin NK, Iscimen R, Gurbet A, Kahveci F, Kutlay O. Dexmedetomidine sedation for the treatment of tetanus in the intensive care unit. Br J Anaesth. 2007;99:599-600
  14. Ozer-Cınar S, Isıl CT, Paksoy I. Dexmedetomidine in the management of severe tetanus. Indıan J Anaesth. 2014;58:96-7.